ArticleCompanion animal health and genetics2026
Clinical factors, service type, and clinical outcomes associated with canine parvovirus in dogs presented at the KNUST Veterinary Teaching Hospital in Kumasi, Ghana.
Article in Companion animal health and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCanine parvovirus (CPV) continues to be a predominant cause of morbidity and mortality among dogs worldwide. In Ghana, data on clinical predictors, service type (inpatient or outpatient), and clinical outcomes in dogs afflicted by CPV is limited. This cross-sectional study, conducted at a Veterinary Teaching Hospital in Kumasi, Ghana, assessed the clinical factors associated with CPV diagnosis, service delivery types, and clinical outcomes in dogs. Diagnosis was based on compatible clinical signs and results from a Vcheck CPV antigen test kit with the V200 analyser (Bionote Inc., Korea), with dogs classified as CPV-positive or CPV-negative based on test results. Demographics, vaccination status, clinical signs, service type, and outcome data were recorded. Odds ratios were reported with 95% confidence intervals, and a significance threshold of p < 0.05 was set for regression analyses.
resultsA total of 129 CPV-positive dogs were diagnosed, with an overall mortality rate of 26.4% (34/129), compared to 8.5% (7/82) among CPV-negative dogs. Haemorrhagic diarrhoea (OR = 6.84), vomiting (OR = 2.75), lower body weight (OR = 0.94 per kg increase), and complete loss of appetite (OR = 4.29) were significant independent predictors of CPV infection. CPV-positive dogs were significantly more likely to require inpatient care than CPV-negative dogs (OR = 7.57, p < 0.001).
conclusionsCPV has a significant impact on dog morbidity and mortality in Ghana, with important emotional and financial consequences for affected dog owners. Classic gastrointestinal signs may assist in the clinical assessment of suspected cases in practice. CPV-positive dogs had higher inpatient care rates and mortality compared to CPV-negative dogs. These findings emphasise the need for improved vaccination uptake, client education, and clinical management practices to reduce CPV-related mortality in affected populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.